News NICE approval for Keytruda a 'milestone' in lung cancer But drug will not be funded for longer than two years.
News Call for NHS to invest in digital pathology Cancer Research UK report highlights pressure on pathology services
News Pfizer fears rough ride with NICE over breast cancer drug Concerns over NICE's treatment of add-on therapies.
News Juno halts CAR-T trial again after 2 more deaths Doubts over Juno CAR-T therapy after two more trial deaths.
News Janssen drug approved in combination against myeloma FDA backs Darzalex in multiple myeloma second line.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
